Primary Sjögren's Syndrome Research and Therapy: Has a New Dawn Arrived?

Wan Fai Ng

doi:10.2174/138920112802273272

Primary Sjögren's Syndrome Research and Therapy: Has a New Dawn Arrived?

Wan Fai Ng

Newcastle University

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	1987-1988
Number of pages	2
Journal	Current Pharmaceutical Biotechnology
Volume	13
Issue number	10
DOIs	https://doi.org/10.2174/138920112802273272
Publication status	Published - 2012
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.2174/138920112802273272

Cite this

@article{76dd2abee57d427fb04e70f12a5a8aff,

title = "Primary Sj{\"o}gren's Syndrome Research and Therapy: Has a New Dawn Arrived?",

author = "Ng, \{Wan Fai\}",

year = "2012",

doi = "10.2174/138920112802273272",

language = "English",

volume = "13",

pages = "1987--1988",

journal = "Current Pharmaceutical Biotechnology",

issn = "1389-2010",

publisher = "Bentham Science Publishers",

number = "10",

}

TY - JOUR

T1 - Primary Sjögren's Syndrome Research and Therapy

T2 - Has a New Dawn Arrived?

AU - Ng, Wan Fai

PY - 2012

Y1 - 2012

UR - https://www.scopus.com/pages/publications/84862489973

U2 - 10.2174/138920112802273272

DO - 10.2174/138920112802273272

M3 - Editorial

C2 - 22208650

AN - SCOPUS:84862489973

SN - 1389-2010

VL - 13

SP - 1987

EP - 1988

JO - Current Pharmaceutical Biotechnology

JF - Current Pharmaceutical Biotechnology

IS - 10

ER -

Primary Sjögren's Syndrome Research and Therapy: Has a New Dawn Arrived?

UN SDGs

Access to Document

Other files and links

Cite this